Official Online Store

MENU

ユーグレナのニュースNews

Press Releases

* Please note that the news release contains the content at the time of the announcement and may differ from the latest information.

2015.08.24

New investment companies participate in Real Tech Development Fund
-Dentsu, Tokyo Century Leasing, Kyowa Hakko Kirin, and Aizawa Securities are added to a total of 12 companies, and the fund scale is 3.6 billion yen-

LLC Euglena SMBC Nikko Leave a Nest Capital

 Euglena SMBC Leave a Nest Capital (Headquarters: Minato-ku, Tokyo, Representative: Akihiko Nagata, hereafter ESL) is a venture capital fund that aims to support R & D-type venture companies that develop next-generation advanced technologies. Announcement that Dentsu Co., Ltd., Tokyo Century Lease Co., Ltd., Kyowa Hakko Kirin Co., Ltd., and Aizawa Securities Co., Ltd. have been newly added to the "Next Generation Japan Advanced Technology Development Fund (commonly known as Real Tech * Development Fund)". I will do it. With this new subscription, the number of invested companies will increase by 4 from the initial 8 (April 2015) to a total of 12 companies, and the total fund will be 3.6 billion yen.
 The Real Tech Development Program is not only the funds provided by each operating company that is an investor in the Real Tech Development Fund, but also the provision of management know-how, facilities and equipment, joint research and business development, etc. It is a new type of investment fund that fosters R & D-type venture companies by supporting human resources.
* Real Tech: Technology that involves physical technological development that is not completed only on the WEB. Physical technologies such as robotics, biotechnology, agri, energy, and IoT.

About the roles of the Real Tech Development Fund and new members

■ Main roles of new members

Figure 1

Dentsu : Support for branding and promotion of venture companies
Tokyo Century Leasing : Financial support for R & D-type venture companies
Kyowa Hakko Kirin : Joint research and know-how support in the fields of pharmaceuticals and healthcare
Aizawa Securities : Discovering R & D-type ventures and supporting collaboration with large companies

 

■ Role of existing participating companies
Figure 2

Euglena : Joint research and commercialization support in the bio and agri fields
Leave a Nest : Providing a training program for seed early venture companies
Japan Tobacco : Support for research and venture companies in the healthcare field, etc.
Mitsui Fudosan : Facility support for R & D bases, offices, etc.
Yoshinoya HD : Support for know-how related to development in the restaurant industry and agriculture and livestock technology
Rohto Pharmaceutical : Joint research and know-how support in the fields of pharmaceuticals and healthcare
Kane-dori : Support through product sales of R & D-type venture companies

 

■ About Real Tech Development Fund (HP: www.euglena-investment.jp)
 Our 100% subsidiary of Euglena Investment, SMBC Nikko Securities, Ribanesu "Limited Liability Company was founded three companies Euglena in venture capital funds that SMBC Nikko Ribanesu capital" to management and operation, the investment development of the real tech venture as the main purpose is. There are a total of 12 participating companies, and the fund size will be 3.6 billion yen. By the end of 2015, we aim to increase the number of participating companies to a fund of 5 billion yen or more.

​ ​

-Contact for inquiries from the press-
Euglena Co., Ltd. Public Relations and IR Division

Return to top of page

This website uses cookies to acquire and use access data for the purpose of improving the experience on the site.
When using this site, please agree to the use of cookies.
Please see the "Privacy Policy" for information on site cookies.

agree